Baker McKenzie advised ATB Therapeutics SA on the deal. ATB Therapeutics SA, a Belgian next-generation antibody company, completed a EUR 54 million Series A financing. The...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Biocartis Group NV and its group companies on the deal. Biocartis Group NV and its group companies executed an enforcement by Biocartis’s secured...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Mithra Pharmaceuticals on the deal. Mithra Pharmaceuticals executed a €100 million equity funding from Goldman Sachs International. Mithra is a listed Belgian biotech company...
You must be a Standard 1 Year member to access this content.
